Company / Return on Assets (ROA)
Moleculin Biotech, Inc. Return on Assets (ROA) History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Assets (ROA)
-117.7%
FY2025
5-year range
-175.9% / -20.6%
FY2021-FY2025
Trend
+33.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Return on Assets (ROA) returned to growth in FY2025 after 3 years of decline, reaching -117.7%.
Based on SEC 10-K filings.
-117.7% in FY2025 with a 5-year CAGR of -72.2%.
Declined from -75.9% to -117.7% over the past 2 years.
Return on Assets (ROA) over time
Growth rates
- 3-Year Change
- -90.1pp
- 5-Year Change
- -72.2pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, return on assets (roa) increased 33.1% year-over-year.
- Peak return on assets (roa) was recorded in FY2016.
- Lowest return on assets (roa) in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -3.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Assets (ROA)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -117.7% | +33.1% |
| FY2024 | -175.9% | -131.6% |
| FY2023 | -75.9% | -174.4% |
| FY2022 | -27.7% | -34.1% |
| FY2021 | -20.6% | +54.6% |
| FY2020 | -45.5% | +3.3% |
| FY2019 | -47.1% | +6.0% |
| FY2018 | -50.1% | -148.4% |
| FY2017 | -20.2% | -340.9% |
| FY2016 | -4.6% | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026